Centers for Disease Control and Prevention (CDC): Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes

Centers for Disease Control and Prevention (CDC): Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes

The CDC released a study which found that, telemedicine was used by approximately half of US adults diagnosed with prediabetes or diabetes in 2021, with a noticeable decrease in use in 2022. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.